PDLIM7 and nasopharyngeal carcinoma: NPC shows EBV type II pattern, where Epstein–Barr nuclear antigen 1 (EBNA1), latent membrane protein 1 (LMP1), LMP2A, LMP2B and Epstein–Barr virus-encoded small RNA (EBER) are expressed, and each of the EBV antigens contribute differentially to the development of NPC and modulation of immunosurveillance [6,7].